The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.

Saved in:
Bibliographic Details
Title: The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.
Authors: Patil T; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: https://twitter.com/TejasPatilMD., Gao D; Department of Biostatistics, University of Colorado School of Medicine, Aurora, CO, USA., Watson A; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Sakamoto M; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Nie Y; Yale Cancer Center, Yale University, New Haven, CT, USA., Gibson A; Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada., Dean ML; Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada., Yoder BA; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Miller E; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Stalker M; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Aisner DL; Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA., Bunn PA; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Schenk EL; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA., Marmarelis ME; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Bennati C; Department of Hematology and Oncology, AUSL della Romagna, Ravenna, Italy., Navani V; Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada., Zhang Y; Hunan Cancer Hospital, Xiangya School of Medicine, Changsha, China., Camidge DR; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Jan; Vol. 199, pp. 108040. Date of Electronic Publication: 2024 Nov 25.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39615411
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Patil+T%22">Patil T</searchLink>; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: https://twitter.com/TejasPatilMD.<br /><searchLink fieldCode="AU" term="%22Gao+D%22">Gao D</searchLink>; Department of Biostatistics, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Watson+A%22">Watson A</searchLink>; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Sakamoto+M%22">Sakamoto M</searchLink>; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Nie+Y%22">Nie Y</searchLink>; Yale Cancer Center, Yale University, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Gibson+A%22">Gibson A</searchLink>; Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Dean+ML%22">Dean ML</searchLink>; Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Yoder+BA%22">Yoder BA</searchLink>; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Miller+E%22">Miller E</searchLink>; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Stalker+M%22">Stalker M</searchLink>; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Aisner+DL%22">Aisner DL</searchLink>; Department of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Bunn+PA%22">Bunn PA</searchLink>; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Schenk+EL%22">Schenk EL</searchLink>; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Marmarelis+ME%22">Marmarelis ME</searchLink>; Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bennati+C%22">Bennati C</searchLink>; Department of Hematology and Oncology, AUSL della Romagna, Ravenna, Italy.<br /><searchLink fieldCode="AU" term="%22Navani+V%22">Navani V</searchLink>; Glans-Look Lung Cancer Research, Cumming School of Medicine, University of Calgary, Alberta, Canada.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Hunan Cancer Hospital, Xiangya School of Medicine, Changsha, China.<br /><searchLink fieldCode="AU" term="%22Camidge+DR%22">Camidge DR</searchLink>; Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228800805%22">Lung cancer (Amsterdam, Netherlands)</searchLink> [Lung Cancer] 2025 Jan; Vol. 199, pp. 108040. <i>Date of Electronic Publication: </i>2024 Nov 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>8800805 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-8332 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201695002%22">01695002 </searchLink><i>NLM ISO Abbreviation: </i>Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39615411
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.lungcan.2024.108040
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108040
    Titles:
      – TitleFull: The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Patil T
      – PersonEntity:
          Name:
            NameFull: Gao D
      – PersonEntity:
          Name:
            NameFull: Watson A
      – PersonEntity:
          Name:
            NameFull: Sakamoto M
      – PersonEntity:
          Name:
            NameFull: Nie Y
      – PersonEntity:
          Name:
            NameFull: Gibson A
      – PersonEntity:
          Name:
            NameFull: Dean ML
      – PersonEntity:
          Name:
            NameFull: Yoder BA
      – PersonEntity:
          Name:
            NameFull: Miller E
      – PersonEntity:
          Name:
            NameFull: Stalker M
      – PersonEntity:
          Name:
            NameFull: Aisner DL
      – PersonEntity:
          Name:
            NameFull: Bunn PA
      – PersonEntity:
          Name:
            NameFull: Schenk EL
      – PersonEntity:
          Name:
            NameFull: Marmarelis ME
      – PersonEntity:
          Name:
            NameFull: Bennati C
      – PersonEntity:
          Name:
            NameFull: Navani V
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Camidge DR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1872-8332
          Numbering:
            – Type: volume
              Value: 199
          Titles:
            – TitleFull: Lung cancer (Amsterdam, Netherlands)
              Type: main
ResultId 1